In a report released today, Serge Belanger from Needham maintained a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report). The company's shares closed last Thursday at $30.75. According to TipRanks.com, Belanger has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -3.4% and a 38.2% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, KalVista Pharmaceuticals, and Phasebio Pharmaceuticals. Amphastar Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $38.25. See the top stocks recommended by analysts >> The company has a one-year high of $44.46 and a one-year low of $17.56.
https://www.tipranks.com/news/blurbs/amphastar-pharmaceuticals-amph-receives-a-hold-from-needham-3?utm_source=advfn.com&utm_medium=referral
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Amphastar Pharmaceuticals Charts.
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Amphastar Pharmaceuticals Charts.